RWM
TNYA icon

Rezny Wealth Management’s Tenaya Therapeutics TNYA Stock Holding History

Rezny Wealth Management’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-40,000
Closed -$27.7K – 40
2026
Q1 		$27.7K Buy
+40,000
New +$29.5K 0.01% 38

Other funds holding TNYA

MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
EL
EWA LLC Pittsbugh, Pennsylvania $548M AUM 35.14% 1-Year Est. Return
AWM
Avior Wealth Management Omaha, Nebraska $3.8B AUM 23.28% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
VWM
Vermillion Wealth Management Rosemount, Minnesota $427M AUM 12.63% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Rezny Wealth Management's TNYA Position: Q2 2026 in Review

Rezny Wealth Management sold out of Tenaya Therapeutics (TNYA) in Q2 2026, closing a stake of 40,000 shares — an estimated $27.7K sold.

Rezny Wealth Management first reported a position in TNYA in Q1 2026 and held it in 1 quarter. The position peaked at $27.7K in Q1 2026. 9 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • Rezny Wealth Management reported no remaining Tenaya Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Rezny Wealth Management sold 40,000 Tenaya Therapeutics shares in Q2 2026, an estimated $27.7K.
  • Rezny Wealth Management first reported a position in Tenaya Therapeutics in Q1 2026 and held it in 1 quarter.
  • Rezny Wealth Management's Tenaya Therapeutics position peaked at $27.7K in Q1 2026.
  • 9 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on Rezny Wealth Management's 13F filing for Q2 2026, filed 17 Jul 2026.